The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Gallimycin-100 InjectionThis page contains information on Gallimycin-100 Injection for veterinary use.
The information provided typically includes the following:
- Gallimycin-100 Injection Indications
- Warnings and cautions for Gallimycin-100 Injection
- Direction and dosage information for Gallimycin-100 Injection
Gallimycin-100 InjectionThis treatment applies to the following species:
100 mg per mL
Antibacterial for Cattle
For Intramuscular Injection
NADA 012-123, Approved by FDA
Gallimycin®-100 Injection is an erythromycin preparation formulated in a sterile solution for intramuscular administration only.
Each mL contains:
In a non-aqueous, buffered, alcohol base sterile solution.
Gallimycin-100 Injection Indications and Usage
Gallimycin®-100 Injection is indicated for the treatment of bovine respiratory disease (shipping fever complex and bacterial pneumonia) associated with Pasteurella multocida organisms susceptible to erythromycin.
Treated animals should not be slaughtered for food within 6 days of the last injection. Temporary tissue irritation follows injection. To avoid excessive trim do not slaughter cattle within 21 days of the last injection. Do not use in female dairy cattle greater than 20 months of age.
A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
In animals weighing over 200 lbs., the neck region is the preferred site for deep intramuscular injection. Since there may be a transient swelling or soreness at the site of injection, it is advisable, when more than one treatment is required, to vary the site of the injection. This is achieved by alternating sides of the neck if necessary, alternating between the leg and neck muscles. No more than 10 mL should be injected at any one site (in small calves under 200 lbs. no more than 4 mL should be injected per site and then only in the heavy muscles of the leg). Swelling or soreness encountered at the site of injection is usually mild, transient and disappears in 2 to 4 days. Deep intramuscular injections will minimize the incidence of local soreness and swelling.
Dosage and Administration
Deep intramuscular injection into the heavy neck muscles, or if necessary for alternating injection sites, into the heavy muscular portion of the leg muscle (round). In calves under 200 lbs., deep intramuscular injection into the heavy muscles of the leg only. Administer 4 mL/100 lbs. body weight (4 mg/lb body weight) once daily for up to 5 days as needed. Use a 1-inch to 2-inch, 16 or 18 gauge needle depending on the animal’s size.
STORE AT ROOM TEMPERATURE, 15-30°C (59-86°F).
PROTECT FROM FREEZING.
Gallimycin is supplied in sterile 100 mL multiple-dose, rubber-stoppered vials.
Restricted Drug (California); Use only as directed.
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
Manufactured by: Bimeda-MTC Animal Health, Inc., Cambridge, ON N3C 2W4
Manufactured for: Bimeda, Inc. Le Sueur, MN 56058
Bimeda, Inc. and Bimeda-MTC Animal Health Inc. are Divisions of Cross Vetpharm Group Ltd.
Gallimycin is a Registered Trademark of Bimeda, Inc.
100 mL (3.4 Fl Oz)
NAC No.: 13990163
Div. Cross Vetpharm Group, Ltd.
ONE TOWER LANE-SUITE 2250, OAKBROOK TERRACE, IL, 60181
|Every effort has been made to ensure the accuracy of the Gallimycin-100 Injection information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-10-31